ugichem Closes € 2m Financing Round

Companies › Health Care ♦ Published: August 9, 2011; 15:48 ♦ (Vindobona)

The Tyrolean biotech company secured funding from two major investors and a research grant from the Austrian Research Promotion Agency.

ugichem Closes € 2m Financing Round / Picture: © Vindobona.org

Innsbruck-based ugichem announced the closing of a € 2m follow-up financing. The present lead investor The BioScience Venture Group and the new investor V+ GmbH & Co Fonds 3 KG participated in this € 1.4m equity financing round as well as notable Swiss private investors. Additionally ugichem received a € 0.6m research grant from the Austrian Research Promotion Agency…

or Log In

Fast News Search
Related News
Intercell Is Looking for Financial Investors (July 19, 2011)
Intercell to Cut Jobs and Research Budget (June 8, 2011)
Sanochemia Confirms the Turnaround and Returns to Profitability (May 13, 2011)
R&D: High Activities of Austrian Firms with Foreign Co-Investors (January 4, 2011)
Economic Chamber in Tokyo: Biotechnology as an Opportunity (December 6, 2010)
Expansion Potential of Austrian Pharmaceutical Industry in Japan (December 1, 2010)
Read More
Ugichem, High Tech Industry, Pharmaceutical Industry, Health Policy, Funding, Tyrol
Featured
Second Coronavirus Lockdown in Austria: Which Rules Apply?
Austria's Hard Lockdown: So what applies now?
Austria's Second Hard Lockdown: So what applies now? - Live Updates
Austria Faces Hard Lockdown
Second Coronavirus Lockdown: Which Rules Apply for your Business in Austria?
List of National Days of the Home Countries of All Foreign Missions and Delegations in Vienna, Austria
See latest Vindobona Newsletter